Cargando…

Combined Oral Contraceptive Effects on Low-Grade Chronic Inflammatory Mediators in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

Polycystic ovary syndrome is associated with dyslipidemia, dysglycemia, metabolic syndrome, and low-grade chronic inflammation, which increase the risks for cardiovascular disease. Combined oral contraceptives may affect the mediators of low-grade chronic inflammation with potential additive risk in...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Medeiros, Sebastião Freitas, de Medeiros, Matheus Antônio Souto, Santos, Nayara de Souza, Barbosa, Bruna Barcelo, Yamamoto, Márcia Marly Winck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286752/ https://www.ncbi.nlm.nih.gov/pubmed/30595838 http://dx.doi.org/10.1155/2018/9591509

Ejemplares similares

Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome
por: Medeiros, Sebastião Freitas de, et al.
Publicado: (2022)

Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review: PCOS and COVID-19 relationship
por: de Medeiros, Sebastião Freitas, et al.
Publicado: (2022)

Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age
por: de Medeiros, Sebastião Freitas, et al.
Publicado: (2019)

The Role of C-Peptide as Marker of Cardiometabolic Risk in Women With Polycystic Ovary Syndrome: A Controlled Study
por: de Medeiros, Sebastiao Freitas, et al.
Publicado: (2018)

Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
por: de Medeiros, Sebastião Freitas, et al.
Publicado: (2017)

Should Subclinical Hypothyroidism Be an Exclusion Criterion for the Diagnosis of Polycystic Ovary Syndrome?
por: de-Medeiros, Sebastião Freitas, et al.
Publicado: (2017)

Morphology and Biochemistry of Ovulation
por: Medeiros, Sebastião Freitas de, et al.
Publicado: (2021)

Prevalence of Elevated Glycated Hemoglobin Concentrations in the Polycystic Ovary Syndrome: Anthropometrical and Metabolic Relationship in Amazonian Women
por: de Medeiros, Sebastiao Freitas, et al.
Publicado: (2014)

Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome
por: de Medeiros, Sebastião Freitas
Publicado: (2017)

Abnormal Bleeding During Menopause Hormone Therapy: Insights for Clinical Management
por: de Medeiros, Sebastião Freitas, et al.
Publicado: (2013)

An Update on Contraception in Polycystic Ovary Syndrome
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
por: Yang, Young-Mo, et al.
Publicado: (2015)

Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome
por: Park, Chan-Hong, et al.
Publicado: (2020)

PMON208 METFORMIN, SPIRONOLACTONE AND ORAL CONTRACEPTIVES IN POLYCYSTIC OVARY SYNDROME: A NETWORK META-ANALYSIS
por: Rodriguez-Gutierrez, Rene, et al.
Publicado: (2022)

Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits
por: de Melo, Anderson Sanches, et al.
Publicado: (2017)

Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2017)

Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
por: Ignatov, Atanas, et al.
Publicado: (2020)

Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome
por: Mehrabian, Ferdous, et al.
Publicado: (2016)

Contraception for Women with Polycystic Ovary Syndrome: Dealing with a Complex Condition
por: Spritzer, Poli Mara
Publicado: (2022)

First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?
por: Decanter, Christine, et al.
Publicado: (2013)

Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
por: Amiri, Mina, et al.
Publicado: (2020)

Influence of combined oral contraceptives on the periodontal condition
por: DOMINGUES, Roberta Santos, et al.
Publicado: (2012)

Lean Women on Metformin and Oral Contraceptives for Polycystic Ovary Syndrome Demonstrate a Dehydrated Osteosarcopenic Phenotype: A Pilot Study
por: Stefanaki, Charikleia, et al.
Publicado: (2019)

Change of the vaginal microbiome with oral contraceptive therapy in women with polycystic ovary syndrome: a 6-month longitudinal cohort study
por: Hong, Xiang, et al.
Publicado: (2023)

Can the genetic polymorphisms of the folate metabolism have an influence in the polycystic ovary syndrome?
por: dos Santos, Tayssia Beatriz, et al.
Publicado: (2019)

NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features
por: Recuero, Amanda Medeiros, et al.
Publicado: (2022)

Polymorphisms rs2010963 and rs833061 of the VEGF gene in polycystic ovary syndrome
por: Vicente, Anna Luiza Silva Almeida, et al.
Publicado: (2022)

Mandibular Inferior Cortex Erosion on Dental Panoramic Radiograph as a Sign of Low Bone Mineral Density in Postmenopausal Women
por: Carmo, Juliana Zigart Brum, et al.
Publicado: (2017)

The effects of exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: protocol for a systematic review and meta-analysis
por: Woodward, Amie, et al.
Publicado: (2019)

The effects of physical exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: a systematic review and meta-analysis
por: Woodward, Amie, et al.
Publicado: (2019)

Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome but Affects Amino Acid Metabolism in Sera of Obese Girls With Polycystic Ovary Syndrome
por: Tayachew, Beza, et al.
Publicado: (2022)

The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome
por: Acmaz, G., et al.
Publicado: (2019)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Polycystic Ovary Syndrome and Metabolic Syndrome: Clinical and Laboratory Findings and Non-Alcoholic Fatty Liver Disease Assessed by Elastography
por: Lavor, Claruza Braga Holanda, et al.
Publicado: (2022)

Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial
por: Behboudi-Gandevani, Samira, et al.
Publicado: (2019)

Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study
por: Kumarendran, Balachandran, et al.
Publicado: (2021)

Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights
por: Mancini, Antonio, et al.
Publicado: (2021)

Physical Performance Regarding Handgrip Strength in Women with Polycystic Ovary Syndrome
por: Kogure, Gislaine Satyko, et al.
Publicado: (2020)

Oral contraceptive pills induced hemichorea in an adolescent female with polycystic ovarian disease
por: Sharmila, Vijayan, et al.
Publicado: (2015)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2214ercohv8pfm3poajbth5ujp